CORT today
$73.69-$0.84 (-1.13%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourBullish
1 hourSymmetric Triangle
15 minDescending Triangle
5 minSymmetric Triangle
Daily trend turns up above $126.38
Key levels
Resistance$84.13
Resistance$77.38
Support$59.03
Support$49.83
Latest news & SEC filings
NewsCorcept Therapeutics Insider Sells Shares Valued at $2,046,351
SEC FilingCorcept Therapeutics Inc filed an insider trading report (Form 4)
AnalystPiper Sandler keeps Overweight on Corcept Therapeutics, lifts target to $173
All CORT news →About Corcept Therapeutics
Corcept Therapeutics is a drugmaker focused on cortisol-modulating medicines for hormonal, cancer, liver and nerve conditions. It sells Korlym, a mifepristone tablet, plus a generic equivalent in the United States, targeting physicians who treat excess cortisol, also called Cushing's syndrome. Its pipeline includes relacorilant for excess cortisol and for a form of ovarian cancer resistant to platinum chemotherapy, miricorilant for fatty liver disease, and dazucorilant for ALS.
Based on the company's 10-K filed Feb 24, 2026.
Nasdaq · Healthcare
CORCEPT THERAPEUTICS INC (CORT)
What Is the Price Target for CORT?
SEPT Low Target
$50.00
SEPT Mid Target
$116.50
SEPT High Target
$165.00
Analyst Consensus
$116.50
Is CORT a Buy or Sell Right Now?
Thesis
- •Revenue growing 12.8% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CORT.
Start Free Trial →Is CORT Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$85.97
34
Moat Score
NONE
4/9
Piotroski Score
33.5
Altman Z-Score
What Is Smart Money Doing with CORT?
Insider Signal
SELLING
0 buys / 12 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Maduck Sean | other | Buy | 13,159 | $109K | Nov 3, 2026 |
| Maduck Sean | other | Sale | 8,617 | $707K | Nov 3, 2026 |
| Maduck Sean | other | Sale | 4,542 | $376K | Nov 3, 2026 |
| Maduck Sean | other | Buy | 11,841 | $98K | Nov 2, 2026 |
| Maduck Sean | other | Sale | 11,841 | $964K | Nov 2, 2026 |
| Vieira Roberto Wandenkolk | officer | Buy | 8,333 | $180K | Nov 2, 2026 |
| Vieira Roberto Wandenkolk | officer | Sale | 6,657 | $537K | Nov 2, 2026 |
| Vieira Roberto Wandenkolk | officer | Sale | 1,676 | $137K | Nov 2, 2026 |
| WILSON JAMES N | director | Sale | 6,654 | $762K | Oct 15, 2026 |
| WILSON JAMES N | director | Sale | 3,046 | $351K | Oct 15, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CORT Growth Story
Revenue YoY
12.8%
3yr Revenue CAGR
23.7%
EPS Growth YoY
-33.33%
FCF Growth YoY
-27.7%
Revenue Trend
STRONG
Dark Pool Trades for CORT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CORT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:26:04 | $74.53 | 13,607 | $$1.0M | BUY |
| 21:00:45 | $74.53 | 1,532 | $$114K | BUY |
| 21:00:45 | $74.53 | 1,020 | $$76K | BUY |
| 21:00:45 | $74.53 | 1,417 | $$106K | BUY |
| 21:00:34 | $74.53 | 1,517 | $$113K | BUY |
5 dark pool trades shown · $$1.4M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CORCEPT THERAPEUTICS INC (CORT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CORT — frequently asked questions
What is CORT stock price today?
CORCEPT THERAPEUTICS INC (CORT) is at $73.69, down 1.13% (-$0.84) at the Nov 12, 2026 close.
Why is CORT stock moving today?
Latest CORT news — Nov 5, 2026: Corcept Therapeutics Insider Sells Shares Valued at $2,046,351 · Nov 4, 2026: Corcept Therapeutics Inc filed an insider trading report (Form 4)
What is the CORT price target?
The average analyst price target for CORT is $116.50, ranging from $50 to $165, based on 6 analysts.
What do analysts rate CORT?
Analyst ratings for CORT: 3 Buy, 9 Hold, 2 Sell — consensus Hold.
Did CORT beat earnings?
CORT last reported on Jul 29, 2026: EPS $0.36 vs $0.00 expected — a beat.
What is CORT's P/E ratio?
CORT trades at a P/E of 196.8 vs a Healthcare average of 17.8.
Does CORT pay a dividend?
CORT does not currently pay a dividend.
What are CORT support and resistance levels?
Support: $59.03, $49.83, $40.28. Resistance: $77.38, $84.13, $90.00.
What are insiders doing with CORT?
Insider activity: SELLING, 0 buys and 12 sells in the last 90 days.
What is the latest news on CORT?
Nov 5, 2026: Corcept Therapeutics Insider Sells Shares Valued at $2,046,351 · Nov 4, 2026: Corcept Therapeutics Inc filed an insider trading report (Form 4) · Nov 4, 2026: Piper Sandler keeps Overweight on Corcept Therapeutics, lifts target to $173